388 studies found for:    Open Studies | "Diabetes Mellitus, Type 1"
Show Display Options
Rank Status Study
21 Recruiting Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment
Condition: Diabetes Mellitus, Type 1
Intervention: Procedure: human pancreatic islet transplantation
22 Not yet recruiting Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric New-onset Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Diabetic Ketoacidosis
Interventions: Drug: Glargine;   Drug: IV insulin;   Other: Electrolyte Correction;   Other: Correction of Fluid Loss
23 Recruiting Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Faster-acting insulin aspart;   Drug: insulin aspart
24 Recruiting Empagliflozin as Adjunctive to inSulin thErapy in Type 1 Diabetes Over 52 Weeks (EASE-2)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo
25 Not yet recruiting PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Gan & Lee insulin glargine followed by Lantus;   Drug: Lantus followed by Gan & Lee insulin glargine
26 Recruiting Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
27 Not yet recruiting Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Faster-acting insulin aspart;   Drug: insulin degludec;   Drug: insulin aspart
28 Not yet recruiting A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: NNC0143-0406;   Drug: insulin aspart
29 Not yet recruiting Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Condition: Type 1 Diabetes
Interventions: Drug: Victoza®;   Drug: Placebo
30 Recruiting Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump
Condition: Type 1 Diabetes Mellitus
Interventions: Other: Telecare;   Other: Conventional therapy
31 Recruiting Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Conditions: Type 1 Diabetes Mellitus;   New-onset Type 1 Diabetes Mellitus;   T1DM;   T1D
Interventions: Drug: Tocilizumab (TCZ);   Drug: Placebo
32 Recruiting Beta Cell Function in (Pre)Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Glucose;   Device: Continuous glucose monitoring
33 Recruiting Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec;   Drug: insulin glargine
34 Recruiting Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: NNC0114-0006;   Drug: liraglutide;   Drug: placebo
35 Recruiting Unified Safety System (USS) Virginia Closed-Loop Versus Sensor Augmented Pump Therapy for Hypoglycemia Reduction in Type 1 Diabetes
Condition: Type 1 Diabetes Mellitus
Interventions: Device: Diabetes Assistant (DiAs) (Unified Safety System (USS) Virginia);   Device: Sensor-Augmented Pump Therapy (placebo)
36 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Condition: Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
37 Recruiting Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy
Condition: Type 1 Diabetes
Intervention: Device: Stem Cell Educator
38 Recruiting Pancreas Volume in Preclinical Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: MRI, US, and blood samples
39 Recruiting Pre-POINT-Early Study
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Oral Insulin;   Drug: Placebo
40 Recruiting AbATE Follow-Up Study
Condition: Diabetes Mellitus, Type 1

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years